Coagulation factor 2 thrombin receptor (F2R), a key component in the thrombosis process, has been demonstrated up-regulated in various cancers and was associated with several protumoral responses, including primary growth, invasion, metastasis, and angiogenesis [62–66]. The gene discussed is F2R; the disease is cancer.